BU Team Behind NobleGen's Sequencing Tech Advances Fabrication Method as Firm Seeks Series A Funding
The research team behind the Optipore sequencing strategy adopted by NobleGen Biosciences has published a new proof-of-principle study outlining the steps for fabricating nanopore arrays from solid-state material, as the company itself works to secure Series A financing.
BU Team Demos Microfluidic 'Flu Chip' as Multiple Firms Seek to Commercialize Sample Prep Component
This article has been updated from a previous version to clarify that Wave 80 is evaluating the SPE technology but has not licensed it. By Ben Butkus
By Julia Karow This article has been updated to include information about Roche/IBM and Genia.
Noblegen Biosciences has been awarded a $182,000 one-year phase I Small Business Innovation Research grant from the National Human Genome Research Institute to develop its "optipore" sequencing technology, the company disclosed this month.
New Products: Oct 11, 2011
Illumina has launched several products related to its MiSeq platform, including TruSeq Custom Amplicon Kits, Nextera DNA sample prep kits, and its BaseSpace Cloud Environment for storage and analysis.
Jun 14, 2011
Paired Ends: Jun 14, 2011
Jan 11, 2011
Sep 14, 2010
Jul 20, 2010
Jul 13, 2010
Paired Ends: Jul 13, 2010
May 25, 2010